Literature DB >> 19581014

Trials and tribulations in charged particle radiotherapy.

Michael Goitein1.   

Abstract

A number of aspects of radiotherapy using protons and ions such as carbon and neon are discussed, focusing less on the oft-enumerated advantages or potential advantages of these particles as on those aspects which are, or may be, problematic. First, for protons and so-called heavy ions separately, the potential advantages and disadvantages of the particles, on physical and radiobiological grounds, are reviewed and some outstanding problems, both technical and scientific, are enumerated. Then, mention is made of the danger that financial pressures can lead to suboptimal medical care of patients. Finally, the issue of clinical trials, and especially randomized clinical trials, is addressed. On the one hand, very few randomized trials have been reported. On the other hand, there is a widespread desire to see trials of charged particle therapy undertaken. The ethical considerations are briefly reviewed and it is concluded that they pose strong limitations on the types of trials which can be undertaken. Nevertheless, some clinical trials would certainly be appropriate and desirable and a number are suggested, under the categories of retrospective non-randomized clinical trials, prospective non-randomized clinical trials, and prospective-randomized clinical trials. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581014     DOI: 10.1016/j.radonc.2009.06.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

2.  Proton beam radiotherapy: report of the first ten patients treated at the "Centro Nazionale di Adroterapia Oncologica (CNAO)" for skull base and spine tumours.

Authors:  Roberto Orecchia; Viviana Vitolo; Maria Rosaria Fiore; Piero Fossati; Alberto Iannalfi; Barbara Vischioni; Anurita Srivastava; Jeffrey Tuan; Mario Ciocca; Silvia Molinelli; Alfredo Mirandola; Gloria Vilches; Andrea Mairani; Barbara Tagaste; Marco Riboldi; Giulia Fontana; Guido Baroni; Sandro Rossi; Marco Krengli
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

Review 3.  The physical basis and future of radiation therapy.

Authors:  T Bortfeld; R Jeraj
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

4.  A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.

Authors:  Matthew M Ladra; Samantha K Edgington; Anita Mahajan; David Grosshans; Jackie Szymonifka; Fazal Khan; Maryam Moteabbed; Alison M Friedmann; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  Radiother Oncol       Date:  2014-10-16       Impact factor: 6.280

5.  Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients.

Authors:  Alfredo E Echeverria; Matthew McCurdy; Richard Castillo; Vincent Bernard; Natalia Velez Ramos; William Buckley; Edward Castillo; Ping Liu; Josue Martinez; Thomas Guerrero
Journal:  Radiother Oncol       Date:  2012-11-02       Impact factor: 6.280

Review 6.  Proton therapy for brain tumours in the area of evidence-based medicine.

Authors:  Damien C Weber; Pei S Lim; Sebastien Tran; Marc Walser; Alessandra Bolsi; Ulrike Kliebsch; Jürgen Beer; Barbara Bachtiary; Tony Lomax; Alessia Pica
Journal:  Br J Radiol       Date:  2019-05-20       Impact factor: 3.039

7.  Effects of Alpha Particle and Proton Beam Irradiation as Putative Cross-Talk between A549 Cancer Cells and the Endothelial Cells in a Co-Culture System.

Authors:  Hélène Riquier; Denis Abel; Anne-Catherine Wera; Anne-Catherine Heuskin; Géraldine Genard; Stéphane Lucas; Carine Michiels
Journal:  Cancers (Basel)       Date:  2015-03-18       Impact factor: 6.639

8.  Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines.

Authors:  Sarah Dehne; Clarissa Fritz; Stefan Rieken; Daniela Baris; Stephan Brons; Thomas Haberer; Jürgen Debus; Klaus-Josef Weber; Thomas E Schmid; Stephanie E Combs; Daniel Habermehl
Journal:  Front Oncol       Date:  2017-03-13       Impact factor: 6.244

9.  An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range.

Authors:  David Robert Grimes; Daniel R Warren; Mike Partridge
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Proton therapy and the European Particle Therapy Network: The past, present and future.

Authors:  D C Weber; J A Langendijk; C Grau; J Thariat
Journal:  Cancer Radiother       Date:  2020-08-01       Impact factor: 1.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.